EZH2 as a Novel Target for Aggressive Clear Cell Renal Cell Carcinoma

被引：0
|
作者：
Friedman, Paul [1 ]
Christie, Alana [1 ]
Xie, Xian-Jin [1 ]
Rakheja, Dinesh [1 ]
Brugarolas, James [1 ]
Kapur, Payal [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
914
引用
收藏
页码：230A / 230A
页数：1
相关论文
共 50 条
  • [1] EZH2 as a Novel Target for Aggressive Clear Cell Renal Cell Carcinoma
    Friedman, Paul
    Christie, Alana
    Xie, Xian-Jin
    Rakheja, Dinesh
    Brugarolas, James
    Kapur, Payal
    LABORATORY INVESTIGATION, 2016, 96 : 230A - 230A
  • [2] Investigating the role of EZH2 as a therapeutic target in clear cell renal cell carcinoma (ccRCC)
    Wei, Darmood
    Ricketts, Christopher J.
    Schmidt, Laura S.
    Yang, Youfeng
    Vocke, Cathy D.
    Linehan, William M.
    CANCER RESEARCH, 2016, 76
  • [3] Inhibition of EZH2 overcomes resistance to sunitinib in clear cell renal cell carcinoma models
    Adelaiye-Ogala, Remi M.
    Chintala, Sreenivasulu
    Shen, Li
    Orillion, Ashley
    Ciamporcero, Eric
    Elbanna, May
    Miles, Kiersten Marie
    Gillard, Bryan
    Buck, Michael
    Pili, Roberto
    CANCER RESEARCH, 2015, 75
  • [4] Expression of EZH2 in renal cell carcinoma as a novel prognostic marker
    Lee, Hye Won
    Choe, Misun
    PATHOLOGY INTERNATIONAL, 2012, 62 (11) : 735 - 741
  • [5] EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma
    Xu, Z. Q.
    Zhang, L.
    Gao, B. S.
    Wan, Y. G.
    Zhang, X. H.
    Chen, B.
    Wang, Y. T.
    Sun, N.
    Fu, Y. W.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (01): : 41 - 49
  • [6] EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma
    Z. Q. Xu
    L. Zhang
    B. S. Gao
    Y. G. Wan
    X. H. Zhang
    B. Chen
    Y. T. Wang
    N. Sun
    Y. W. Fu
    Clinical and Translational Oncology, 2015, 17 : 41 - 49
  • [7] MiR-138 Induces Renal Carcinoma Cell Senescence by Targeting EZH2 and Is Downregulated in Human Clear Cell Renal Cell Carcinoma
    Liang, Jiaqian
    Zhang, Yajing
    Jiang, Guosong
    Liu, Zhouqiang
    Xiang, Wei
    Chen, Xuanyu
    Chen, Zhaohui
    Zhao, Jun
    ONCOLOGY RESEARCH, 2013, 21 (02) : 83 - 91
  • [8] Using tumor spheroids to evaluate the efficacy of EZH2 inhibitors in clear cell renal cell carcinoma (ccRCC)
    Wei, Darmood
    Yang, Youfeng
    Ricketts, Christopher J.
    Sourbier, Carole
    Schmidt, Laura S.
    Linehan, William M.
    CANCER RESEARCH, 2017, 77
  • [9] EZH2, a potential therapeutic target in Merkel cell carcinoma
    Durand, M.
    Mouchard, A.
    Esnault, C.
    Samimi, M.
    Kervarrec, T.
    Touze, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S191 - S191
  • [10] The Relationship between EZH2 Expression and Renal Cell Carcinoma
    Lee, H. W.
    Park, J. Y.
    Hwang, I.
    Jung, H. R.
    Kwon, S. Y.
    Kang, Y. N.
    Kim, S. P.
    Kwon, K.
    Lee, S. S.
    Choe, M. S.
    LABORATORY INVESTIGATION, 2012, 92 : 223A - 223A
12345